Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
FDA sharply limits use of Johnson & Johnson shot due to rare blood clots
https://www.washingtonpost.com/health/2022/05/05/fda-johnson-and-johnson-vaccine/Federal regulators announced new restrictions Thursday on the Johnson & Johnson coronavirus vaccine, saying the risk of a rare and life-threatening blood clot syndrome outweighed the benefits of the vaccine for people who are 18 or older and can get another shot, unless they would otherwise remain unvaccinated.
The FDA said only people who are unable to receive other vaccines because they are not accessible or clinically appropriate should receive the Johnson & Johnson vaccine.
The Johnson & Johnson vaccine has been associated with a rare, but potentially deadly blood clotting and bleeding syndrome called thrombosis with thrombocytopenia syndrome, or TTS. The condition usually occurs within one to two weeks of vaccination, and a commonly used treatment to treat clotting, heparin, can cause additional harm.
An updated analysis of safety data through March 18 found that there were 60 confirmed cases of the blood-clotting syndrome, including nine that resulted in death. Even with quick treatment, vaccine recipients can rapidly worsen, with long-term health consequences.
